BP Just Got a Wall Street Double Upgrade: Argus, RBC Both Turn Bullish on Recovery Story

BP (NYSE:BP) conscionable received a uncommon same-day treble upgrade from Wall Street. Argus moved BP banal to Buy from Hold, and RBC Capital lifted the banal to Outperform from Sector Perform with a 700 GBp terms target. The simultaneous bullish displacement signals coordinated condemnation that BP's betterment communicative is yet taking signifier nether caller CEO Meg O'Neill.

For semipermanent investors, the calls warrant a person look, though BP's past of mendacious starts demands measured optimism. The dual endorsement from Argus and RBC adds credibility to a turnaround thesis that has eluded the banal for years.

The Analyst's Case

Argus cited BP's Q1 2026 net beat, accrued upstream production, materially higher realized refining margins, and beardown lipid trading contributions. The steadfast flagged little terms realizations arsenic a partial offset, yet viewed operational momentum arsenic decisive.

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and BP wasn't 1 of them. Get them present FREE.

RBC's thesis leaned connected structural deleveraging. The steadfast sees the existent commodity terms situation arsenic different accidental for BP to deleverage, pointing to caller exploration occurrence and caller absorption arsenic catalysts that bring an "opportunity to reconstruct capitalist confidence."

Company Snapshot

BP is simply a London-based integrated lipid and state large operating bp, Castrol, Amoco, Aral, ampm, and bpx Energy. Q1 2026 EPS came successful astatine $1.24 versus $0.5321 estimated, a 133% surprise, connected gross of $52.26 billion.

BP CEO Meg O'Neill is targeting $20 cardinal successful divestments by 2027 and plans to discontinue $4.3 cardinal successful hybrid bonds, portion reiterating FY2026 capex of $13 to $13.5 billion.

Why the Move Matters Now

BP banal has trailed U.S. peers for years, a spread our caller sum of BP's turnaround propulsion has tracked closely. Year to date, BP shares are up 27%, up of Chevron (NYSE:CVX) astatine 21%, Exxon Mobil (NYSE:XOM) astatine 23%, and Shell (NYSE:SHEL) astatine 16%.